VCM
MNTA

Versant Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Versant Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-908
Closed -$30K – 1606
2020
Q2 		$30K Buy
908
+32
+4% +$1.02K 0.01% 321
2020
Q1 		$23K Buy
876
+118
+16% +$3.29K 0.01% 337
2019
Q4 		$14K Hold
758
– – 0.01% 593
2019
Q3 		$9K Buy
758
+246
+48% +$2.97K ﹤0.01% 775
2019
Q2 		$6K Sell
512
-122
-19% -$1.62K ﹤0.01% 939
2019
Q1 		$9K Buy
+634
New +$8.1K ﹤0.01% 957
2016
Q1 		– Sell
-538
Closed -$7K – 1513
2015
Q4 		$7K Buy
+538
New +$9K ﹤0.01% 871

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Versant Capital Management's MNTA Position: Q3 2020 in Review

Versant Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 908 shares — an estimated $30K sold.

Versant Capital Management first reported a position in MNTA in Q4 2015 and held it in 7 quarters. The position peaked at $30K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Versant Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Versant Capital Management sold 908 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $30K.
  • Versant Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2015 and held it in 7 quarters.
  • Versant Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $30K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Versant Capital Management's 13F filing for Q3 2020, filed 2 Nov 2020.